Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
06/2012
06/21/2012US20120156284 Enhanced biological autologous tissue adhesive composition and methods of preparation and use
06/21/2012US20120156282 Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
06/21/2012US20120156281 Meningococcal Vaccine Based on Lipooligosaccharide (LOS) and Neisseria Meningitidis Protein
06/21/2012US20120156265 Conformable tissue repair implant capable of injection delivery
06/21/2012US20120156251 Cationic oil-in-water emulsions
06/21/2012US20120156247 Biocomposition stimulant of the immune system, anti-tumour and anti-hiv
06/21/2012US20120156243 Norovirus vaccine formulations
06/21/2012US20120156242 An Antigenic Peptide Derived From Influenza Virus And A Method For Selecting Anti-Influenza Virus Antibody
06/21/2012US20120156241 Rescue of influenza virus
06/21/2012US20120156239 Optimized vaccines to provide protection against ebola and other viruses
06/21/2012US20120156238 Herpes virus backbone for viral vaccine and vaccine based thereon
06/21/2012US20120156237 Novel Antitoxin and Vaccine Platform Based on Nodavirus VLPS
06/21/2012US20120156236 Neisseria meningitidis antigens and compositions
06/21/2012US20120156235 Antibodies Against And Methods For Producing Vaccines For Respiratory Syncytial Virus
06/21/2012US20120156228 Methods, Kits, and Compositions for Generating New Hair Follicles and Growing Hair
06/21/2012US20120156227 Proteins modified with (amino) monosaccharide-biotin adduct
06/21/2012US20120156219 Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/21/2012US20120156211 Porphyromonas gingivalis polypeptides
06/21/2012US20120156196 Anti-anthrax antibody, formulations thereof, and methods of use
06/21/2012US20120156195 Human-Murine Chimeric Antibodies Against Respiratory Syncytial Virus
06/21/2012US20120156190 Influenza Prevention And Treatment Composition
06/21/2012US20120156176 Thermoresponsive, biodegradable, elastomeric material and uses therefor
06/21/2012US20120156174 Novel bacteriophage and antibacterial composition comprising the same
06/21/2012US20120156173 Fusarium and other pathogenic fungi and mycotoxin biocontrol
06/21/2012US20120156172 New lactic acid bacteria having its inhibitory effect on avian influenza virus infection and composition containing the same
06/21/2012US20120156166 Inhibitors of flaviviridae viruses
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/21/2012US20120156145 Use of Titanium-Based Materials as Bactericides
06/21/2012US20120156144 Foamable Compositions, Kits and Methods for Hyperhidrosis
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/21/2012DE102010055566A1 New compounds conjugating gyrase-inhibiting substances with catechol structural units, are gyrase inhibitors, useful as biologically active substances, and for treating bacterial infection
06/21/2012DE102010055322A1 Antibakteriell und antimykotisch wirkende Substanzen Antibacterial and antifungal substances acting
06/21/2012CA2822039A1 Sulfur derivatives as chemokine receptor modulators
06/21/2012CA2822003A1 Imidazopyridines as respiratory syncytial virus antiviral agents
06/21/2012CA2822002A1 Azaindoles as respiratory syncytial virus antiviral agents
06/21/2012CA2822001A1 Azabenzimidazoles as respiratory syncytial virus antiviral agents
06/21/2012CA2822000A1 Indoles as respiratory syncytial virus antiviral agents
06/21/2012CA2821823A1 Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
06/21/2012CA2821492A1 Vaccine antigens that direct immunity to conserved epitopes
06/21/2012CA2821268A1 Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof
06/21/2012CA2819894A1 Anti-viral compounds
06/21/2012CA2819317A1 Compounds useful for treating aids
06/21/2012CA2819137A1 Wear resistant antimicrobial compositions and methods of use
06/20/2012EP2465935A2 Recombinant human interferon-like proteins
06/20/2012EP2465580A1 Polycyclic carbamoylpyridone derivatives having hiv integrase inhibitory activity
06/20/2012EP2465538A2 Use of immunesuppressant receptor
06/20/2012EP2465522A1 Chemerin-15h and its use for treatment of inflammation and endotoxic shock
06/20/2012EP2465520A2 Epitope sequences
06/20/2012EP2465509A1 Oligosaccharide composition for treating acute respiratory tract infections
06/20/2012EP2465502A1 Compounds useful for treating AIDS
06/20/2012EP2464665A1 Human monoclonal antibody against s. aureus derived alpha-toxin and its use in treating or preventing abscess formation
06/20/2012EP2464664A1 Antibodies against human respiratory syncytial virus (rsv) and methods of use
06/20/2012EP2464641A1 Pyrimidine compounds as tuberculosis inhibitors
06/20/2012EP2464383A2 Compositions and methods for the therapy and diagnosis of influenza
06/20/2012EP2464379A1 Vaccine having a peptide adjuvant for eliciting a specific immune response to treat viral infection and other conditions
06/20/2012EP2464345A2 Treatment of viral infections
06/20/2012EP2464334A1 Compositions and methods for treating fungal infection of the nail
06/20/2012EP2464232A1 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
06/20/2012EP2364731A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2359855A9 Methods of administering anti-TNFalpha antibodies
06/20/2012EP2075258B1 Antibody against rgd in amino acid sequence of extracellular matrix protein and production method and use of the same
06/20/2012EP1912996B1 Macrocyclic inhibitors of hepatitis c virus
06/20/2012EP1910378B1 Hepatitis c inhibitor peptide analogs
06/20/2012EP1805134B1 4-aminotetracyclines and methods of use thereof
06/20/2012EP1691837B1 Ip-10 antibodies and their uses
06/20/2012EP1527080B1 Campylobacter glycans and glycopeptides
06/20/2012EP1452541B1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
06/20/2012EP1311267B1 A retroviral immunotherapy
06/20/2012EP1305292B1 Biphenyl carboxamides
06/20/2012EP1252182B1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA
06/20/2012CN1942201B Methods of modulating cytokine activity, related reagents
06/20/2012CN1879661B Use of nocardia rubra cell wall skeleton in preparation of medicine for resisting mycotic infection
06/20/2012CN1550236B Protein stability in aqueous solution
06/20/2012CN102510864A Heterocyclic antiviral compounds
06/20/2012CN102504042A Method for removing endotoxin from bacteria capsular polysaccharide
06/20/2012CN102504024A Antibodies that bind human interleukin-18 and methods of making and using
06/20/2012CN102504023A Method for preparing egg yolk antibody, egg yolk antibody prepared by method and application of egg yolk antibody
06/20/2012CN102504017A Novel Enterococcus and Streptococcus strains and bacteriocins
06/20/2012CN102504014A Peptidomimetic protease inhibitors
06/20/2012CN102504006A Steroid saponin compound in siberian fritillary bulb
06/20/2012CN102504001A 3, 5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo [4,5-d]pyrimidin-2-one compounds and prodrugs thereof
06/20/2012CN102503999A Demalonyl azalomycin F derivatives, preparation method thereof and use in preparing microbicides
06/20/2012CN102503994A Method of treating clostridium difficile-associated diarrhea
06/20/2012CN102503954A Imidazole derivative and preparation method and application thereof
06/20/2012CN102503942A Fluoroquinolone derivative and preparation and medicinal application thereof
06/20/2012CN102503906A Formyl hydroxylamine type peptide deformylase inhibitor containing oxazole ring, as well as preparation method and use thereof
06/20/2012CN102503903A HIV inhibiting 1,2,4-triazines
06/20/2012CN102503901A Zole antifungal compounds, and preparation method and application thereof
06/20/2012CN102503900A (Z)-1-(1-substituted benzyl-5-methyl-1H-1,2,3-triazole-4-yl)-3-substituted benzyl-3-hydroxy-2-propylene-1-ketone compound and preparation method and application thereof
06/20/2012CN102503896A Methylacryloyl-benzimidazole (sulfur) ketone derivative and application of serving as antibacterial agent thereof
06/20/2012CN102500033A Anti-infection venous catheter and preparation method thereof
06/20/2012CN102499983A Application of HepG2.2.15 cell autophagy corpuscle in preparing hepatitis b virus (HBV) therapeutic vaccines
06/20/2012CN102499982A Method for producing trivalent inactivated vaccine against Haemophilus parasuis infection
06/20/2012CN102499975A Traditional Chinese medicine compound externally used paste for treating mumps
06/20/2012CN102499974A Medicament for inhibiting skin fungi and preparation method thereof
06/20/2012CN102499965A Traditional Chinese medicinal composition for fumigation for preventing hand-foot-and-mouth disease
06/20/2012CN102499953A Process for extracting total phenyl propanoid from paulownia bark of paulownia tomentosa (original variety) by adopting supercritical CO2 fluid technology
06/20/2012CN102499949A Ointment for treating chapped hands and feet
06/20/2012CN102499947A Traditional Chinese medicine preparation for treating bedsore and inflammatory pain around knee joint and preparation method thereof
06/20/2012CN102499944A Nanometer silver antibiotic and antiviral compound liquid and its preparation method and products
1 ... 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 ... 1798